In two other families (index Her3 and Her5, Table 2), DNA samples from altogether four family members diagnosed with other cancer types (basal cell carcinoma, prostate cancer, adenocarcinoma, and renal cancer, respectively) were available for testing, but all turned out as noncarriers. This evidence concerns the gene ERBB3 and prostate cancer.